Leukemia
Leukemia is a cancer of blood-forming tissues and is one of the most common cancers diagnosed in children. Types include acute lymphoblastic leukemia and acute myeloid leukemia.

Pediatric oncology is a specialised field of cancer care focused on the diagnosis, treatment and management of cancer in children. Childhood cancers require an approach that takes into account the child's age, development, cancer type, stage and overall health.
Care may involve a combination of surgery, chemotherapy, radiation therapy, immunotherapy and other specialised treatments depending on the diagnosis and treatment plan. Support for the child and family is also an important part of comprehensive cancer care.
Pediatric oncology focuses on cancers that occur during childhood and adolescence. Childhood cancers are different from many adult cancers and require treatment strategies tailored to the child's specific diagnosis.
Pediatric cancer care can involve diagnosis, staging, treatment, recovery, follow-up and supportive care. Depending on the cancer, treatment may require a combination of surgery, chemotherapy, radiation therapy, stem cell transplantation or newer systemic therapies.
Because children are still growing and developing, treatment planning also considers long-term health, development and quality of life.
Pediatric oncology extends beyond treating the tumour. Children and their families may require emotional, psychological, nutritional and supportive care throughout the cancer treatment journey.
Childhood cancer can sometimes present with symptoms that are also seen in common childhood illnesses. Persistent, unusual or unexplained symptoms should be evaluated by a healthcare professional.
The diagnostic approach for pediatric cancer depends on the symptoms and suspected condition. Investigations may be used to confirm or rule out cancer and determine the extent of disease.
Early and accurate diagnosis helps the oncology team develop an appropriate treatment plan.
Pediatric cancers include several different diseases. Treatment and prognosis depend on the specific cancer, its biological characteristics, stage and the child's overall condition.
Leukemia is a cancer of blood-forming tissues and is one of the most common cancers diagnosed in children. Types include acute lymphoblastic leukemia and acute myeloid leukemia.
Lymphoma affects lymphoid tissues. Childhood lymphoma includes Hodgkin lymphoma and non-Hodgkin lymphoma, with treatment depending on the specific subtype and extent of disease.
Neuroblastoma develops from immature nerve cells and commonly arises in the sympathetic nervous system. Treatment depends on risk group and disease stage.
Wilms' tumor is a kidney cancer that primarily affects children. Treatment may involve surgery, chemotherapy and, in selected cases, radiation therapy.
Rhabdomyosarcoma is a soft-tissue cancer that develops from cells associated with skeletal muscle. Management may involve multiple treatment modalities.
Retinoblastoma is a cancer of the retina that mainly affects young children. Early diagnosis is important for treatment and preservation of vision where possible.
Osteosarcoma is a primary bone cancer that often develops in the long bones. Treatment commonly involves systemic therapy and surgery.
Children can also develop other solid tumours and rare cancers. Evaluation by an appropriate specialist helps establish the diagnosis and determine the most suitable treatment pathway.
Solid tumours can arise in different organs and tissues. Their management depends on tumour type, location, stage and whether the tumour can be safely removed surgically.
Cancer staging helps doctors understand the extent of disease and plan appropriate treatment. The staging system differs according to the type of pediatric cancer. In some cancers, stages range from localised disease to more advanced disease with spread to other parts of the body.
Pediatric cancer treatment is individualised according to the cancer type, stage, risk group, tumour biology, age and overall health of the child. Treatment may involve one or more modalities.
Surgery may be used to remove solid tumours when complete or appropriate surgical removal is possible. The surgical plan depends on the tumour's location, size and relationship to surrounding structures.
Chemotherapy uses medicines to destroy cancer cells or control their growth. It may be used before surgery, after surgery or as the primary treatment for cancers such as leukemia and lymphoma.
Radiation therapy uses high-energy radiation to target cancer cells. Its use in children depends on the cancer type, age, location and potential long-term effects.
Immunotherapy helps the immune system recognise and attack cancer cells. Certain immunotherapies may be appropriate for specific pediatric cancers and clinical situations.
Hematopoietic stem cell transplantation may be recommended for selected blood cancers and other conditions when intensive treatment and stem cell rescue are appropriate.
Depending on the cancer's biological features, treatment may include targeted medicines or other advanced therapies. The suitability of these options is determined by the oncology team.
Pediatric cancer treatment affects the child and the entire family. Comprehensive care therefore includes more than treating the cancer itself.
Children who complete cancer treatment may require regular follow-up to monitor recovery, development, late effects of treatment and overall health. Follow-up care is tailored to the child's diagnosis and previous treatment.
Dr. Nitin Singhal is a surgical oncologist with experience in complex cancer surgery and multidisciplinary oncology care. Pediatric cancer treatment should be planned according to the child's specific diagnosis, age, tumour characteristics and overall health.
When surgery is indicated for a pediatric solid tumour, the surgical approach is selected after careful evaluation of the tumour and the child's clinical condition. Where required, treatment can be coordinated with medical oncology, radiation oncology, pathology, radiology and other specialists.
Common questions about childhood cancer symptoms, diagnosis, treatment and specialist care.
Pediatric oncology is the specialised field of medicine concerned with diagnosing and treating cancer in children and adolescents. It includes care for blood cancers such as leukemia and lymphoma as well as solid tumours.
Possible warning signs include unexplained weight loss, persistent headaches, unexplained lumps, persistent swelling or pain, unusual bruising or bleeding, recurrent infections, persistent fatigue and certain eye changes. These symptoms can also occur in non-cancerous conditions, so medical evaluation is important when symptoms persist.
Common pediatric cancers include leukemia, lymphoma, neuroblastoma, Wilms' tumor, rhabdomyosarcoma, retinoblastoma and osteosarcoma. Children can also develop other less common solid tumours.
Diagnosis depends on the suspected cancer and may include blood tests, imaging studies, biopsy and other specialised investigations. Some conditions may require additional tests to determine whether cancer has spread.
Treatment depends on the specific cancer and may include surgery, chemotherapy, radiation therapy, immunotherapy, stem cell transplantation or targeted treatments. Many children receive a combination of treatments as part of a carefully planned cancer treatment strategy.
Surgery is an important treatment for many pediatric solid tumours when the tumour can be safely removed. The role of surgery depends on the tumour's type, location, stage and relationship to surrounding organs and tissues.
Chemotherapy uses medicines that destroy cancer cells or stop them from growing. Depending on the cancer, chemotherapy may be used before surgery, after surgery, together with other treatments or as the main treatment.
Outcomes vary significantly depending on the type of cancer, stage, biological characteristics, response to treatment and overall health. Advances in pediatric oncology have improved outcomes for many childhood cancers, but prognosis is individual and should be discussed with the treating oncology team.
Follow-up is an important part of pediatric cancer care. Children may require monitoring after treatment to assess recovery, development, overall health and possible late effects of treatment. Follow-up plans are individualised according to the child's cancer and treatment history.
Parents should discuss persistent, unusual or unexplained symptoms with a pediatrician or appropriate specialist. If investigations suggest or confirm cancer, specialist oncology assessment can help determine the diagnosis, stage and appropriate treatment options.
If your child has been diagnosed with cancer or requires evaluation for a suspected tumour, discuss the diagnosis and available treatment options with an experienced oncology team.
Dr. Nitin Singhal has been recognised for his contribution to cancer care and surgical oncology, reflecting his commitment to advanced surgical techniques, clinical excellence and patient-centred care.
Surgical oncology training from Tata Memorial Hospital, Mumbai.
Expertise across complex and multidisciplinary cancer surgery.
Honoured for excellence in healthcare and surgical oncology.
Focus on evidence-based and personalised cancer treatment.
Recognition that reflects a continued commitment to excellence in cancer care.
